Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (165), Bone Fractures
...a phase III trial of Aclasta for the prevention of new clinical fractures following a hip fracture. This trial, dubbed the Recurrent Fracture Trial, enrolled 2,100 subjects who were treated with ...
View Page

2.  Newly Approved Drug Therapies (748) Arixtra, Organon, Sanofi-Synthelabo,
...has been approved as a preventative treatment for deep vein thrombosis (DVT) in adults undergoing hip fracture, hip replacement, or knee replacement surgery. It is adminstered through a single dose, prefilled syringe ...
View Page

3.  Study Posting (2246) Trial #136019, Colon Cancer, Duarte, CA
...a history of one or more of the following conditions: stroke, knee or hip arthritis, hip fracture, heart failure, prior heart attack, heart disease, lung disease, circulation problems, kidney disease, diabetes, different ...
View Page

4.  Newly Approved Drug Therapies (961) Reclast (zoledronic acid), Novartis,
...endpoints were the incidence of morphometric vertebral fractures at 3 years and the incidence of hip fractures over a median duration of 3 years. Effect on vertebral fractures over three years Reclast ...
View Page

5.  Study Posting (799) Trial #161729, Hip Replacement, Boston, MA
...at Boston University. The study is designed to address mobility and functioning in persons with hip fracture. People who qualify for this study will receive either: •a DVD-based home exercise program ...
View Page

6.  Study Posting (799) Trial #156509, *Healthy Patient Studies, Boston, MA
...at Boston University. The study is designed to address mobility and functioning in persons with hip fracture. People who qualify for this study will receive either: •a DVD-based home exercise program ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (171), Hormone Replacement Therapy: Menopause
...were reported, including a 37% reduction in cases of colorectal cancer and fewer cases of hip fractures, the overall health risks were found to exceed the benefits. The study -- stopped after an ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (111), Osteoporosis
...once yearly, 15 minute infusion. The primary endpoint was the number of new spine and hip fractures over three years compared to placebo. Secondary endpoints included reducing the incidence of non-spine ...
View Page

9.  CenterWatch: New Medical Therapies in Disease Category (355), Orthopedic Surgery
...September 9, 2002 Results of the Penthifra Plus study involving 656 subjects undergoing surgery for hip fracture showed that Arixtra (fondaparinux) administered for four weeks significantly reduces the incidence of deep venous ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (315), Hip Replacement
...September 9, 2002 Results of the Penthifra Plus study involving 656 subjects undergoing surgery for hip fracture showed that Arixtra (fondaparinux) administered for four weeks significantly reduces the incidence of deep venous ...
View Page

11.  CenterWatch: New Medical Therapies in Disease Category (147), Thrombosis
...September 9, 2002 Results of the Penthifra Plus study involving 656 subjects undergoing surgery for hip fracture showed that Arixtra (fondaparinux) administered for four weeks significantly reduces the incidence of deep venous ...
View Page

12.  Newly Approved Drug Therapies (26) Fosamax (alendronate sodium), Merck,
...osteoporosis causes more than 1.3 million fractures, including 500,000 spinal fractures, 250,000 hip fractures, and 240,000 wrist fractures. Bone is constantly being rebuilt (or remodeled) throughout life in ...
View Page